UNIVERSITY OF FLORIDA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1853-01-01

Employees: 10K

Market Cap: -

Website: http://www.ufl.edu

Clinical Trials

Regional Anesthesia for Head and Neck Reconstruction

Phase 4

Withdrawn

Conditions: Pain, Postoperative

Interventions: Drug: Regional Anesthesia

First Posted Date: 2020-03-11

Last Posted Date: 2020-03-18

Lead Sponsor: University of Florida

Registration Number: NCT04304716

Locations: 🇺🇸
University of Florida, Jacksonville, Florida, United States

Repetitive Transcranial Magnetic Stimulation (rTMS) for Dystonia and Tremor

Not Applicable

Completed

Conditions: Tremor
Dystonia

Interventions: Device: repetitive Transcranial Magnetic Stimulation (rTMS)
Other: Control group

First Posted Date: 2020-03-06

Last Posted Date: 2023-08-21

Lead Sponsor: University of Florida

Target Recruit Count: 12

Registration Number: NCT04299087

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients

Phase 4

Recruiting

Conditions: Intraocular Pressure
Oncology

Interventions: Drug: TIVA
Drug: Balanced anesthesia

First Posted Date: 2020-02-21

Last Posted Date: 2024-05-30

Lead Sponsor: University of Florida

Target Recruit Count: 100

Registration Number: NCT04281017

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Non-invasive Nerve Stimulation and Cognitive Training to Improve Cognitive Performance in Healthy Older Adults

Not Applicable

Active, not recruiting

Conditions: Aging

Interventions: Device: Transcutaneous vagal nerve stimulation (tVNS)
Behavioral: cognitive training

First Posted Date: 2020-02-19

Last Posted Date: 2024-12-04

Lead Sponsor: University of Florida

Target Recruit Count: 7

Registration Number: NCT04276805

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸
University of Arizona, Tucson, Arizona, United States

GPx Activity in Subjects With Aortic Stenosis Undergoing TAVR

Withdrawn

Conditions: Glutathione Peroxidase Activity
Aortic Stenosis
Transcatheter Aortic Valve Replacement

Interventions: Diagnostic Test: Blood draw to measure GPx activity
Diagnostic Test: Blood draw to measure SOD activity
Diagnostic Test: Blood draw to measure Lp(a) levels

First Posted Date: 2020-02-13

Last Posted Date: 2021-06-30

Lead Sponsor: University of Florida

Registration Number: NCT04268160

Locations: 🇺🇸
University of Florida, Jacksonville, Florida, United States

Cognitive Enhancement Through Computerized Training

Not Applicable

Terminated

Conditions: Alcohol Use Disorder

Interventions: Behavioral: Inhibitory Control Training
Behavioral: Working Memory Training
Behavioral: Bias Modification Training

First Posted Date: 2020-01-28

Last Posted Date: 2024-12-13

Lead Sponsor: University of Florida

Target Recruit Count: 22

Registration Number: NCT04244032

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Inhibitory Control Smartphone App

Not Applicable

Active, not recruiting

Conditions: Drinking, Alcohol
Drinking Behavior

Interventions: Behavioral: Standard App Version
Behavioral: Control App Version
Behavioral: Experimental, Feedback App Version

First Posted Date: 2020-01-28

Last Posted Date: 2023-09-22

Lead Sponsor: University of Florida

Target Recruit Count: 53

Registration Number: NCT04243759

Locations: 🇺🇸
UF Health at the University of Florida, Gainesville, Florida, United States

Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD

Phase 2

Active, not recruiting

Conditions: C9orf72 Amyotrophic Lateral Sclerosis (ALS)
Frontotemporal Dementia

Interventions: Drug: Metformin

First Posted Date: 2020-01-07

Last Posted Date: 2024-10-18

Lead Sponsor: University of Florida

Target Recruit Count: 18

Registration Number: NCT04220021

Locations: 🇺🇸
UF Health at the University of Florida, Gainesville, Florida, United States

Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination

Early Phase 1

Recruiting

Conditions: Pain

Interventions: Drug: OxyCODONE 5 mg Oral Tablet
Other: Placebo Oxycodone
Other: Placebo oxytocin
Drug: Oxytocin nasal spray
Drug: OxyCODONE 2.5 mg Oral Tablet

First Posted Date: 2020-01-06

Last Posted Date: 2024-12-10

Lead Sponsor: University of Florida

Target Recruit Count: 45

Registration Number: NCT04218409

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Dual Lead Thalamic Deep Brain Recording (DBR)-DBS Interface for Closed Loop Control of Severe Essential Tremor

Not Applicable

Recruiting

Conditions: Essential Tremor

Interventions: Device: Medtronic Summit Rechargable (RC)+S
Procedure: standard ET DBS
Procedure: ipsilateral thalamic (VIM+VO) DBS
Procedure: ipsilateral VO

First Posted Date: 2019-12-30

Last Posted Date: 2024-06-24

Lead Sponsor: University of Florida

Target Recruit Count: 10

Registration Number: NCT04212780

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Home Terms & Conditions Privacy Policy